Choosing the Right In Vitro Assay Shouldn't Be Harder Than Developing Your Therapeutic.
Stop wasting time and resources second-guessing your assay strategy.
Lost in the In Vitro Maze? You Aren't Alone.
When you are developing a novel therapeutic, the sheer volume of in vitro testing options can be overwhelming.
Should you use a 2D cell culture or a complex 3D organoid model?
Which toxicity assay will satisfy regulatory bodies?
Are you choosing a test that is too simple to yield meaningful data, or too complex and costly for your current stage?
Does it align with FDA’s 2.0 NAM approach?
Is it relevant to your modality?
Is the in vitro model relevant for representing the clinical condition?
Every wrong turn costs you precious time and runway. Selecting an inappropriate or overly complex assay can lead to false starts, ambiguous data, and delayed milestones. You need a partner who understands the science behind the screening.
At Vivogenia, we don't just hand you a catalog of tests and expect you to know what to order. Our scientists work backward from your therapeutic goals and regulatory requirements to design a lean, robust, and highly targeted in vitro testing cascade.
How We Work:
Consultation & Strategy: We review your molecule, target, and disease indication to cut through the noise.
Custom Assay Selection: We match your therapeutic to the most predictive models—ranging from high-throughput screening to advanced human-relevant cell models.
Execution & Analysis: We run the tests with rigorous quality control, delivering clear, actionable data that drives your next "Go/No-Go" decision.
In Vitro Assay Finder
Explore alternative testing methods by category.
The tests listed in this widget are intended for informational purposes and does not constitute any professional advice on which tests should be performed for your specific therapeutic target. Please consult us for a more tailored and detailed approach for the purposes of your therapeutic development.
Our Capabilities
We offer a full spectrum of in vitro capabilities, intelligently selected for your specific therapeutic class (Small Molecules, Biologics, Cell/Gene Therapies):
Efficacy & Mechanism of Action (MoA): Target binding, functional assays, and biomarker validation to prove your drug does exactly what it's supposed to do.
ADME & DMPK Screening: Early profiling of absorption, distribution, metabolism, and excretion to flag liabilities before they become expensive problems.
In Vitro Toxicology: Cytotoxicity, genotoxicity, and hepatotoxicity screening using standard cell lines and primary human tissues to ensure a safe profile.
Complex Phenotypic Screening: Advanced 3D cultures, co-cultures, and organ-on-a-chip models when standard 2D assays fall short of mimicking human biology.